美股新聞 標題聯播 · 近 24 小時 305 則 · 28 個來源 · 最新 9/20 06:00
本站只列標題、來源、時間與原文連結,不重製內文;著作權屬原媒體與原作者。新聞稿通路(PR Newswire、Business Wire、GlobeNewswire)是公司自己發的,屬第一手;媒體是轉述。
全部 · EW近 30 天 16 則 · 第 1 / 1 頁
- 投資人可能如何回 dwards Lifesciences (EW)擴 AV 用範圍與經導管瓣膜野心How Investors May Respond To Edwards Lifesciences (EW) Expanded TAVR Access And Transcatheter Valve Ambitions
- Edwards Lifesciences (EW) Stock Looks Reasonable After Medicare TAVR Expansion
- 介入性心臟病學裝置市場按類型、終端使用者 - 全球預測至 2031 年Interventional Cardiology Devices Market by Type, End User - Global Forecast to 2031
- Edwards Lifesciences Sees TAVR Expansion, $2B TMTT Opportunity Ahead
- CMS expands TAVR Medicare coverage to asymptomatic patients
- Edwards Lifesciences Comments on TAVR National Coverage Decision
- Is Edwards Lifesciences Stock Underperforming the Dow?
- Pacific Biosciences (PACB) Up 11.6% Since Last Earnings Report: Can It Continue?
- Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
- Why Is ISRG Investing More Aggressively in R&D Despite Macro Headwinds?
- Unusual Volume in Edwards Lifesciences Put Options Shows Investors Bullish on EW Stock
- Edwards Lifesciences (EW): The Medical Device Leader Behind the TAVR Boom
- Why Is IQVIA (IQV) Up 5.6% Since Last Earnings Report?
- MDT's Q1 Earnings on Deck: How Should You Play the Stock Now?
- Can STERIS Stock Deliver as Its $600 Million Chemistry Bet Scales?
- Is Edwards Lifesciences (EW) A Bargain Following Its Asia Pacific Patient Experience Event?
- Should Investors Buy STERIS as Growth Meets Reasonable Valuation?
- Should You Hold Edwards Lifesciences Stock in Your Portfolio?
- Edwards Lifesciences (EW) Stock Could Be 1% Above Fair Value On Cash Flow And Earnings
中文標題是機器翻譯(NLLB 模型,不外送資料),專有名詞靠對照表,語意以英文原題為準。預設藏掉:選股文與自動生成站(Motley Fool、24/7 Wall St、Trefis、MarketBeat…)、加密幣、律師事務所的股東訴訟廣告、非英文、新聞稿裡的人事任命 / 出席活動 / 得獎、個人理財專欄,以及通路稿標題對不到上市公司的。個股標籤是從標題辨識的(通路標準寫法 (NASDAQ: NVDA)、公司名對照);帶「?」的是從摘要辨識、信心較低。來源等級 A / B / C 只影響精選排序,不是對媒體的評價。